Your browser doesn't support javascript.
loading
The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans.
Di Meglio, Paola; Di Cesare, Antonella; Laggner, Ute; Chu, Chung-Ching; Napolitano, Luca; Villanova, Federica; Tosi, Isabella; Capon, Francesca; Trembath, Richard C; Peris, Ketty; Nestle, Frank O.
Affiliation
  • Di Meglio P; St John's Institute of Dermatology, King's College London and NIHR Biomedical Research Centre, London, United Kingdom.
PLoS One ; 6(2): e17160, 2011 Feb 22.
Article in En | MEDLINE | ID: mdl-21364948

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Receptors, Interleukin / Interleukin-23 / Th17 Cells / Immunity, Cellular / Immune System Diseases Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Receptors, Interleukin / Interleukin-23 / Th17 Cells / Immunity, Cellular / Immune System Diseases Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2011 Type: Article Affiliation country: United kingdom